These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19887380)

  • 21. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells.
    Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B
    Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
    Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
    Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
    Yepes M; Winkles JA
    Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
    Burkly LC; Michaelson JS; Zheng TS
    Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considering TWEAK as a target for therapy in renal and vascular injury.
    Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
    Ho DH; Vu H; Brown SA; Donohue PJ; Hanscom HN; Winkles JA
    Cancer Res; 2004 Dec; 64(24):8968-72. PubMed ID: 15604260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.
    Hammoud L; Xiang F; Lu X; Brunner F; Leco K; Feng Q
    Cardiovasc Res; 2007 Jul; 75(2):359-68. PubMed ID: 17553475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells.
    Muñoz-García B; Madrigal-Matute J; Moreno JA; Martin-Ventura JL; López-Franco O; Sastre C; Ortega L; Burkly LC; Egido J; Blanco-Colio LM
    Cardiovasc Res; 2011 Jan; 89(1):225-33. PubMed ID: 20810696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.
    Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
    Seyed M; Dimario JX
    J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei.
    Walsh S; Pontén A; Fleischmann BK; Jovinge S
    Cardiovasc Res; 2010 Jun; 86(3):365-73. PubMed ID: 20071355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy.
    Novoyatleva T; Janssen W; Wietelmann A; Schermuly RT; Engel FB
    Cytokine; 2013 Oct; 64(1):43-5. PubMed ID: 23764551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.
    Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J
    Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the canine cytokine TWEAK (CD255) and its receptor, Fn14 (CD266).
    Zhang JX; Sang M; Zhao W; Ai HX; Shui Y; Li JF; Song R; Zhang SQ
    Vet Immunol Immunopathol; 2010 Sep; 137(1-2):172-5. PubMed ID: 20452679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TWEAK regulates proliferation and differentiation of adult neural progenitor cells.
    Schölzke MN; Röttinger A; Murikinati S; Gehrig N; Leib C; Schwaninger M
    Mol Cell Neurosci; 2011 Jan; 46(1):325-32. PubMed ID: 21040786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase.
    Liu ZP; Olson EN
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2043-8. PubMed ID: 11854500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
    Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
    J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
    Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
    Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.